JAK1-IN-13 - Search Results | AbMole BioScience

About 4 results found for searched term "JAK1-IN-13" (0.142 seconds)

Cat.No.	Name	Target
M49575	JAK1-IN-13	JAK
	JAK1-IN-13 is an orally active, potent and highly selective inhibitor of JAK1 with an IC50 of 0.044 nM.
M1787	INCB18424	JAK
	Ruxolitinib
	Ruxolitinib (INCB018424) is a first-in-class, potent, selective JAK1/2 inhibitor with an IC50 of 3.3 nM/2.8 nM. It is more than 130-fold more selective for JAK1, JAK2, and JAK3 than JAK3. It can be used in studies related to pemphigus, myelofibrosis and vitiligo.
M3030	S-Ruxolitinib	JAK
	S-Ruxolitinib; INCB18424
	S-Ruxolitinib is the chirality of INCB018424, which is the first potent, selective, JAK1/2 inhibitor to enter the clinic with IC50 of 3.3 nM/2.8 nM, >130-fold selectivity for JAK1/2 versus JAK3.
M5944	Ruxolitinib phosphate	JAK
	INCB018424 phosphate; INCB 018424 phosphate; INCB-018424 phosphate; Ruxolitinib
	Ruxolitinib phosphate(INCB018424 phosphate) is the first potent, selective, JAK1/2 inhibitor to enter the clinic with IC50 of 3.3 nM/2.8 nM, >130-fold selectivity for JAK1/2 versus JAK3.